How an Arrhythmic Heartbeat Develops and What Triggers It

An arrhythmic heart is one that has lost its normal electrical rhythm, beating too fast, too slow, or in a disorganized pattern that disrupts efficient blood flow. The term covers a wide spectrum, from harmless extra beats you might feel as a flutter in your chest to life-threatening conditions like ventricular fibrillation. What makes arrhythmias so varied, and sometimes so dangerous, is that they can arise from dozens of different disruptions in the heart’s finely tuned electrical wiring, and the same person can experience benign skipped beats and a serious rhythm disorder at different points in their life.

How the Heart Keeps Time

Your heart has its own built-in pacemaker: a small cluster of cells in the upper right chamber called the sinoatrial node. This node fires an electrical impulse that spreads through the upper chambers, pauses briefly at a relay station called the atrioventricular node, then races down specialized fibers into the lower chambers, causing the coordinated squeeze that pumps blood. The cells in this conduction system express a fundamentally different set of ion channels than ordinary heart muscle cells, which is what allows them to generate and conduct electrical signals in such a precise sequence.¹ When anything disrupts this sequence, whether a misfiring cluster of cells, a short circuit through scar tissue, or an ion channel that opens when it shouldn’t, the result is an arrhythmia.

What Goes Wrong

Arrhythmias fall into a few broad mechanistic buckets. Some happen because a group of cells fires off electrical impulses on its own, overriding the normal pacemaker. Others occur because an electrical signal gets trapped in a loop, circling through the same patch of tissue over and over again, a phenomenon called reentry. Still others result from cells that are destabilized enough to fire spontaneously after a normal heartbeat, producing what’s called triggered activity.² These mechanisms often overlap. A heart that has been damaged by a prior heart attack, for example, may have scar tissue that creates reentry circuits while also having surviving muscle cells that are electrically irritable enough to trigger abnormal beats on their own.

Atrial Fibrillation and the Stroke Connection

Atrial fibrillation, often called AFib, is the most common sustained arrhythmia. Instead of a single coordinated squeeze, the upper chambers quiver chaotically, sometimes at rates above 300 impulses per minute, though most of those impulses are filtered out before reaching the lower chambers. AFib tends to begin as brief episodes that come and go, but over time it can become persistent or permanent. The reason it progresses is that the arrhythmia itself remodels the atrial tissue. Oxidative stress, inflammation, calcium overload, and the activation of cells that produce scar-like connective tissue all work together to change the electrical and physical properties of the atrium, making it increasingly hospitable to chaotic rhythms.³ This structural remodeling, particularly the fibrosis it creates, is a defining feature of the AFib substrate and a major reason the condition tends to worsen over time.⁴

The danger of AFib extends well beyond the annoyance of a racing or irregular pulse. When the upper chambers stop squeezing effectively, blood pools and stagnates, particularly in a small pouch called the left atrial appendage. Over 90% of the clots responsible for stroke in AFib patients originate from this appendage.⁵ The sluggish blood flow in that pouch is a key part of the process: reduced flow velocity encourages stasis, which promotes clot formation.⁶ Computational modeling has confirmed that people who go on to have strokes tend to have slower blood movement and higher particle residual rates in their appendages compared with AFib patients who don’t have strokes.⁷ This is why blood thinners are such a central part of AFib management: the arrhythmia itself may be tolerable, but the stroke risk it creates is not.

Ventricular Arrhythmias and Scar Tissue

While atrial arrhythmias are common and manageable, arrhythmias that originate in the heart’s lower chambers are the ones most likely to kill. Ventricular tachycardia, a rapid rhythm driven by the ventricles, can cause the heart to pump so inefficiently that blood pressure plummets. If it degenerates into ventricular fibrillation, the ventricles quiver uselessly and cardiac arrest follows within minutes.

The most common setup for ventricular tachycardia after a heart attack is reentry through scar. When heart muscle dies and is replaced by fibrous tissue, thin strands of surviving muscle cells weave through the scar. Electrical signals snake through these strands in a zigzag pattern, slowed by reduced connections between cells and impaired excitability.⁸ That slowed, tortuous conduction creates the conditions for a signal to loop back on itself and circulate endlessly.⁹ The result is a self-sustaining circuit that can fire hundreds of times per minute, outpacing the heart’s normal rhythm.

Inherited Rhythm Disorders

Not all arrhythmias need structural damage to occur. Some people are born with mutations in the genes that encode cardiac ion channels, the molecular gates that control the flow of sodium, potassium, and calcium in and out of heart cells. Since 1995, thousands of such mutations have been identified, and they produce a handful of recognized syndromes: long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, short QT syndrome, and various conduction defects.¹⁰ Whole-exome sequencing studies continue to uncover new mutations, often in the SCN5A gene (which encodes the heart’s main sodium channel) and the KCNQ1 and KCNH2 genes (which encode potassium channels).¹¹

What makes these conditions tricky is that the same syndrome can behave very differently depending on the specific gene involved. In long QT syndrome, for instance, at least seven genetic subtypes have been identified. Beta-blockers are protective in the most common form but appear far less helpful in others.¹² This has pushed the field toward genotype-guided treatment, where the therapy you receive depends not just on your diagnosis but on which mutation you carry. And the overlap with drug-induced arrhythmias is real: certain medications can block the same ion channels that are already impaired in people with subtle, undiagnosed channelopathies, unmasking a dangerous rhythm that would never have appeared otherwise.¹³

The Nervous System as Conductor and Disruptor

The heart doesn’t operate in isolation from the brain. Sympathetic nerves (the “fight or flight” system) and parasympathetic nerves (the “rest and digest” system) constantly adjust heart rate and the electrical properties of cardiac tissue. Their influence on arrhythmias is not straightforward and sometimes even contradictory. In atrial fibrillation, simultaneous activation of both branches is the most common trigger. In ventricular fibrillation during a heart attack, sympathetic activation provokes the arrhythmia while parasympathetic activity helps suppress it. And in Brugada syndrome, the relationship flips: sympathetic stimulation is actually protective.¹⁴

Aging adds another layer. As people get older, the cardiac autonomic nervous system deteriorates, and pathological swings in its activity can produce defective electrical activation and recovery in the heart muscle.¹⁵ This helps explain why arrhythmias become so much more common with age, even in people who have no obvious heart disease.

Everyday Triggers

Several modifiable factors can tip a susceptible heart into arrhythmia, and alcohol is among the best-documented. The so-called “holiday heart syndrome” refers to episodes of atrial fibrillation that follow binge drinking, typically appearing hours after a heavy session rather than during it. The delay has a molecular explanation: alcohol exposure upregulates a specific type of calcium channel in heart cells through a signaling cascade, and this upregulation peaks around eight hours after intake and wanes by 24 hours.¹⁶ Human studies confirm the sequence: heart rate rises during consumption, extra atrial beats increase during the hangover period, and the parasympathetic “rebound” that follows the initial sympathetic surge may further destabilize atrial rhythm.¹⁷

Electrolyte imbalances are another underappreciated trigger. Low potassium and low magnesium don’t just cause arrhythmias on their own; they also interfere with the effectiveness of anti-arrhythmic drugs and amplify the toxicity of others.¹⁸ People on diuretics, those recovering from vomiting or diarrhea, and endurance athletes who sweat heavily are all at risk for these shifts.

Sleep-disordered breathing, particularly obstructive sleep apnea, is one of the strongest and most common comorbid conditions linked to arrhythmias. The repeated airway collapse during sleep produces swings in autonomic nervous system activity, recurrent drops in oxygen, and changes in pressure inside the chest that directly affect heart function. Over time, these nightly insults create both structural and electrical changes in the heart that favor arrhythmia development.¹⁹ The connection is strong enough that the American Heart Association has issued a formal scientific statement on it, and treating sleep apnea has become part of the standard approach to managing recurrent atrial fibrillation.

Detecting Arrhythmias With Wearables and AI

One of the practical challenges with arrhythmias, especially paroxysmal ones that come and go, is catching them in the act. A standard electrocardiogram records only a few seconds of heart rhythm. If the arrhythmia isn’t happening at that moment, the test looks normal. This is where smartwatches and AI are starting to make a real difference.

A recent meta-analysis covering over 17,000 patients found that smartwatches achieved an overall sensitivity of about 95% and specificity of about 97% for detecting atrial fibrillation, with Apple Watch, Samsung, and Withings devices all performing in a broadly similar range.²⁰ Another meta-analysis that separated the two main sensor technologies found that pulse-based sensors were more sensitive than electrocardiogram-based ones for AFib detection.²¹ In real-world daily use, a wristwatch photoplethysmography device identified patients with atrial fibrillation with about 98% sensitivity and a negative predictive value above 99%, meaning a clean reading was very reassuring.²²

Perhaps more intriguing is the use of artificial intelligence to predict arrhythmias before they happen. AI algorithms can analyze a normal-looking electrocardiogram recorded during sinus rhythm and estimate the probability that the person has, or will develop, atrial fibrillation. A deep learning model trained on US Veterans Affairs data predicted AFib within 31 days of a normal ECG with an area under the curve of 0.86, which improved to 0.93 at a validation site with different demographics.²³ In patients who had suffered strokes of unknown origin and had monitoring devices implanted, an AI algorithm identified those who would later be found to have AFib with an area under the curve of about 0.81, and its confidence in the prediction increased as the recording date approached the actual onset of the arrhythmia.²⁴ These tools are still being refined, and performance varies by population; one European screening study found more modest results with an AUC of 0.62 in a narrow-age elderly cohort, though it jumped to 0.80 in a dataset with a wider age range.²⁵ The bottom line is that AI-guided screening is real and advancing quickly, but the accuracy depends heavily on the population being screened.

Treatment Beyond Drugs

Catheter ablation has become a mainstay for treating arrhythmias that don’t respond to or aren’t well suited for medications. In the case of atrial fibrillation, the procedure typically involves electrically isolating the pulmonary veins, where many of the triggering impulses originate. Newer pulsed field ablation technology is generating excitement because it appears to spare surrounding structures that older energy sources can inadvertently injure. In animal studies, high-intensity pulsed field ablation had no effect on the esophagus or phrenic nerve, whereas standard radiofrequency ablation caused deep esophageal injury and acute nerve paralysis.²⁶ That improved safety profile matters because the esophagus sits right behind the left atrium, and esophageal damage has been a rare but feared complication of ablation for years.

For ventricular arrhythmias that carry a risk of sudden death, implantable cardioverter-defibrillators remain a critical tool. These devices monitor the heart’s rhythm continuously and deliver an internal shock when a life-threatening arrhythmia is detected. Landmark trials established their survival benefit, particularly in patients whose hearts pump poorly, with a left ventricular ejection fraction of 35% or below.²⁷ Subcutaneous defibrillators, which avoid threading wires into the heart, have shown strong shock efficacy overall, though first-shock success rates in early data were lower than those seen with traditional transvenous systems.²⁸

Athletes, Chest Impacts, and Arrhythmic Risk

Endurance athletes sit in an unusual position when it comes to arrhythmias. Years of intense training produce structural changes in the heart, including chamber enlargement and wall thickening, that can look alarmingly similar to arrhythmogenic cardiomyopathy on imaging. Telling the two apart is genuinely difficult, and the consequences of getting it wrong run in both directions: miss a cardiomyopathy, and the athlete is at risk of sudden death; overdiagnose one, and a healthy person is barred from sport and subjected to unnecessary anxiety.²⁹

A completely separate athletic risk is commotio cordis, where a blow to the chest triggers ventricular fibrillation in a structurally normal heart. The mechanism is mechanical: the impact creates a sudden stretch of heart muscle during a narrow vulnerable window of the cardiac cycle, activating mechanically sensitive ion channels and producing nonuniform electrical activation that degenerates into fibrillation.³⁰ The timing window is extremely narrow, and the velocity, location, and hardness of the impact all matter. Research in animal models has confirmed that the stretch itself, applied during repolarization, is what opens the door to fibrillation via repolarization inhomogeneity.³¹ Though rare, commotio cordis remains a leading cause of sudden cardiac death in young athletes, and its recognition has driven the push for chest protectors in youth sports and the placement of automated external defibrillators at sporting venues.

Pregnancy and New-Onset Arrhythmias

Pregnancy creates a perfect storm for arrhythmias. Blood volume increases substantially, cardiac output rises, resting heart rate climbs, and hormonal and autonomic shifts change the electrical properties of the heart. These changes can produce new arrhythmias in people who have never had them before or worsen pre-existing ones.³² The most common arrhythmias during pregnancy are extra beats, both atrial and ventricular, which are usually harmless. Sustained arrhythmias like supraventricular tachycardia or atrial fibrillation are less common but can be more concerning because many of the standard drugs used to treat them have uncertain safety profiles in pregnancy. Management typically involves conservative approaches first, with drug therapy reserved for hemodynamically significant arrhythmias, and the choice of medication involves a careful weighing of fetal risk against maternal benefit that doesn’t apply in any other clinical context.